Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wechsler

Showing results (81-90 of 213) with videos related to

Pageof 22
Sort By:
Journal of Neurovirology|June 13, 2015
Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2Xianzhi Jiang, Don Brown, Nelson Osorio, et al.
Journal of Virology|January 1, 1995
Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1H Ghiasi, S L Wechsler, R Kaiwar, et al.
Journal of Virology|November 1, 1988
Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading framesS L Wechsler, A B Nesburn, R Watson, et al.
Journal of Virology|September 5, 2001
Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in miceH Ghiasi, Y Osorio, G C Perng, et al.
Journal of Neurovirology|February 26, 2004
The latency-related gene encoded by bovine herpesvirus 1 can suppress caspase 3 and caspase 9 cleavage during productive infectionGail Henderson, Guey-Chuen Perng, Anthony B Nesburn, et al.
Expert Review of Vaccines|July 25, 2009
New concepts in herpes simplex virus vaccine development: notes from the battlefieldGargi Dasgupta, Aziz A Chentoufi, Anthony B Nesburn, et al.
Immunology|November 21, 1998
The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challengeH Ghiasi, S L Wechsler, S Cai, et al.
Virus Research|October 1, 1996
The UL3 open reading frame of herpes simplex virus type 1 codes for a phosphoproteinH Ghiasi, G C Perng, S Cai, et al.
Journal of Virology|August 21, 2002
Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunityHomayon Ghiasi, Yanira Osorio, Guey-Chuen Perng, et al.
Journal of Virological Methods|February 1, 1994
An improved method for cloning portions of the repeat regions of herpes simplex virus type 1G C Perng, H Ghiasi, R Kaiwar, et al.
Pageof 22

Showing results (81-90 of 213) with videos related to

Sort By:
Pageof 22
Journal of Neurovirology|June 13, 2015
Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2Xianzhi Jiang, Don Brown, Nelson Osorio, et al.
Journal of Virology|January 1, 1995
Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1H Ghiasi, S L Wechsler, R Kaiwar, et al.
Journal of Virology|November 1, 1988
Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading framesS L Wechsler, A B Nesburn, R Watson, et al.
Journal of Virology|September 5, 2001
Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in miceH Ghiasi, Y Osorio, G C Perng, et al.
Journal of Neurovirology|February 26, 2004
The latency-related gene encoded by bovine herpesvirus 1 can suppress caspase 3 and caspase 9 cleavage during productive infectionGail Henderson, Guey-Chuen Perng, Anthony B Nesburn, et al.
Expert Review of Vaccines|July 25, 2009
New concepts in herpes simplex virus vaccine development: notes from the battlefieldGargi Dasgupta, Aziz A Chentoufi, Anthony B Nesburn, et al.
Immunology|November 21, 1998
The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challengeH Ghiasi, S L Wechsler, S Cai, et al.
Virus Research|October 1, 1996
The UL3 open reading frame of herpes simplex virus type 1 codes for a phosphoproteinH Ghiasi, G C Perng, S Cai, et al.
Journal of Virology|August 21, 2002
Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunityHomayon Ghiasi, Yanira Osorio, Guey-Chuen Perng, et al.
Journal of Virological Methods|February 1, 1994
An improved method for cloning portions of the repeat regions of herpes simplex virus type 1G C Perng, H Ghiasi, R Kaiwar, et al.
Pageof 22